Skip to main content
Equibles

BlackRock Inc.

Position in INCY — Incyte Corp

CIK 1364742 New York, NY
Back to INCY Full portfolio

Position in INCY

as of Jun 30, 2024 · filed Aug 13, 2024
Position Value
$1,294,617,319
-$29,392,247 QoQ
Shares Held
21,356,274
-8.1% QoQ
Ownership
10.7%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 91% Shared 0% None 9%

Common Shares in INCY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2024

BlackRock Inc. holds $54,091,702,062 across 441 Biotechnology names. INCY ranks #7 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 21,312,244 $9,989,474,999
2 REGN
Regeneron Pharmaceuticals, Inc.
 8,446,366 $8,877,384,047
3 MRNA
Moderna, Inc.
 25,562,321 $3,035,525,609
4 ALNY
Alnylam Pharmaceuticals, Inc.
 9,547,663 $2,320,082,109
5 BMRN
Biomarin Pharmaceutical Inc
 22,738,349 $1,872,048,264
6 SRPT
Sarepta Therapeutics, Inc.
 10,324,404 $1,631,255,832
7 INCY
Incyte Corp
This page 		21,356,274 $1,294,617,319
8 TECH
BIO-TECHNE Corp
 14,987,870 $1,073,880,877

All Filings in INCY

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2024-06-30 $1,294,617,319 21,356,274
2024-03-31 $1,324,009,566 23,240,470
2023-12-31 $1,525,672,791 24,298,022
2023-09-30 $1,400,689,618 24,245,969
2023-06-30 $1,486,679,142 23,882,396
2023-03-31 $1,491,353,951 20,635,865
2022-12-31 $1,593,339,154 19,837,390
2022-09-30 $1,309,120,331 19,644,663
2022-06-30 $1,447,940,936 19,059,378
2022-03-31 $1,436,953,118 18,093,089
2021-12-31 $1,345,910,689 18,336,658
2021-09-30 $1,197,582,082 17,411,778
2021-06-30 $1,426,111,009 16,951,278
2021-03-31 $1,436,470,727 17,675,289
2020-12-31 $1,549,011,762 17,808,827
2020-09-30 $1,530,589,008 17,055,817
2020-06-30 $1,774,988,203 17,072,119
2020-03-31 $1,121,324,917 15,312,371